Linagliptin, sold under the brand name Tradjenta among others, is a medication used to treat type 2 diabetes (but not type 1) in conjunction with exercise... 11 KB (694 words) - 03:54, 12 April 2024 |
Empagliflozin/linagliptin, sold under the brand name Glyxambi, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. It... 9 KB (546 words) - 00:40, 15 March 2024 |
Metformin (redirect from Linagliptin/metformin) (Kazano, Vipdomet). Linagliptin combined with metformin hydrochloride is sold under the brand name Jentadueto. As of August 2021, linagliptin/metformin is available... 142 KB (13,772 words) - 06:08, 27 April 2024 |
Empagliflozin/linagliptin/metformin, sold under the brand name Trijardy XR, is a drug combination used for the treatment of type 2 diabetes. It is a combination... 8 KB (345 words) - 19:31, 20 December 2023 |
and alogliptin A10BD10 Metformin and saxagliptin A10BD11 Metformin and linagliptin A10BD12 Pioglitazone and sitagliptin A10BD13 Metformin and alogliptin... 6 KB (508 words) - 06:49, 20 December 2023 |
and dapagliflozin. Another triple combination approval for metformin, linagliptin, and empagliflozin followed in 2020. Diabetes medications have four main... 49 KB (5,099 words) - 21:13, 10 May 2024 |
available as the combinations empagliflozin/linagliptin, empagliflozin/metformin, and empagliflozin/linagliptin/metformin. For cardiovascular death, the... 40 KB (3,467 words) - 04:41, 14 May 2024 |
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin... 4 KB (262 words) - 03:35, 22 March 2024 |
Giotrif (afatinib) Jardiance (empagliflozin) Jentadueto / TrajentaDuo (linagliptin / metformin) Metalyse (tenecteplase) Micardis (telmisartan) Micardis... 39 KB (3,271 words) - 14:51, 19 April 2024 |
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin... 36 KB (3,979 words) - 00:47, 14 May 2024 |
BI-1356 was undergoing phase III clinical trials; it was released as linagliptin in May 2011. X-ray crystallography has shown that that xanthine type... 44 KB (5,084 words) - 22:24, 10 May 2024 |
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin... 7 KB (536 words) - 05:58, 18 March 2024 |
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin... 7 KB (446 words) - 21:52, 2 April 2024 |
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin... 11 KB (745 words) - 06:24, 24 March 2024 |